Objective: To investigate the time course of tinnitus changes in patients receiving cochlear implantation (CI) in a prospective, multicenter setting and to determine related factors. Materials and Methods: A total of 79 adult patients who underwent CI were included in this study. We used the same questionnaires sequentially 5 times. The questionnaires included the Visual Analog Scale (VAS) for tinnitus severity, the Tinnitus Handicap Inventory (THI), Beck's Depression Index (BDI), and the Brief Encounter Psychosocial Instrument (BEPSI) for stress assessment. Results: Tinnitus was present in 59 (74.7%) of the 79 study subjects. After CI, tinnitus was eliminated in 10 patients (25%) and improved in 16 patients (40%) of the 40 patients who completed the final questionnaires, and most of the tinnitus reduction occurred in the early period of CI use. In an analysis of psychological functioning with CI, BDI was reduced significantly after CI. Multiple linear regression analysis revealed that preoperative auditory steady-state response (ASSR), THI, and final BDI score were significantly associated with the changes in tinnitus after CI. Conclusions: Most of the tinnitus reduction occurred within 1 month after CI use, and the changes were significantly associated with THI, ASSR, and BDI scores 6 months after CI. CI is a valuable therapeutic modality in tinnitus of a deafened ear.

1.
Andersson G, Freijd A, Baguley DM, Idrizbegovic E: Tinnitus distress, anxiety, depression, and hearing problems among cochlear implant patients with tinnitus. J Am Acad Audiol 2009;20:315-319.
2.
Arts RA, George EL, Chenault MN, Stokroos RJ: Optimizing intracochlear electrical stimulation to suppress tinnitus. Ear Hear 2015;36:125-135.
3.
Baguley DM, Atlas MD: Cochlear implants and tinnitus. Prog Brain Res 2007;166:347-355.
4.
Beck AT, Steer RA, Brown GK: BDI-II, Beck Depression Inventory: Manual, ed 2. San Antonio, Psychological Corporation, 1996.
5.
Bovo R, Ciorba A, Martini A: Tinnitus and cochlear implants. Auris Nasus Larynx 2011;38:14-20.
6.
Chang SA, Tyler RS, Dunn CC, Ji H, Witt SA, Gantz B, Hansen M: Performance over time on adults with simultaneous bilateral cochlear implants. J Am Acad Audiol 2010;21:35-43.
7.
Demajumdar R, Stoddart R, Donaldson I, Proops DW: Tinnitus, cochlear implants and how they affect patients. J Laryngol Otol Suppl 1999;24:24-26.
8.
Hazell JW, McKinney CJ, Aleksy W: Mechanisms of tinnitus in profound deafness. Ann Otol Rhinol Laryngol Suppl 1995;166:418-420.
9.
Huh B, Yim J, Bae J, Choi S, Kim S, Hwang H: The validity of modified Korean-translated BEPSI (Brief Encounter Psychosocial Instrument) as instrument of stress measurement in outpatient clinic. J Korean Acad Fam Med 1996;17:42-53.
10.
Kim DK, Bae SC, Park KH, Jun BC, Lee DH, Yeo SW, Park SN: Tinnitus in patients with profound hearing loss and the effect of cochlear implantation. Eur Arch Otorhinolaryngol 2013;270:1803-1808.
11.
Kloostra FJ, Arnold R, Hofman R, Van Dijk P: Changes in tinnitus after cochlear implantation and its relation with psychological functioning. Audiol Neurootol 2015;20:81-89.
12.
Kompis M, Pelizzone M, Dillier N, Allum J, DeMin N, Senn P: Tinnitus before and 6 months after cochlear implantation. Audiol Neurootol 2012;17:161-168.
13.
McKerrow WS, Schreiner CE, Snyder RL, Merzenich MM, Toner JG: Tinnitus suppression by cochlear implants. Ann Otol Rhinol Laryngol 1991;100:552-558.
14.
Newman CW, Jacobson GP, Spitzer JB: Development of the tinnitus handicap inventory. Arch Otolaryngol Head Neck Surg 1996;122:143-148.
15.
Pan T, Tyler RS, Ji H, Coelho C, Gehringer AK, Gogel SA: Changes in the tinnitus handicap questionnaire after cochlear implantation. Am J Audiol 2009;18:144-151.
16.
Punte AK, Vermeire K, Hofkens A, De Bodt M, De Ridder D, Van de Heyning P: Cochlear implantation as a durable tinnitus treatment in single-sided deafness. Cochlear Implants Int 2011;12(suppl 1):S26-S29.
17.
Quaranta N, Wagstaff S, Baguley DM: Tinnitus and cochlear implantation. Int J Audiol 2004;43:245-251.
18.
Tyler RS: Advantages of disadvantages expected and reported by cochlear implant patients. Am J Otol 1994;15:523-531.
19.
Tyler RS, Noble W, Coelho C: Considerations for the design of clinical trials for tinnitus. Acta Otolaryngol Suppl 2006;556:44-49.
20.
Tyler RS, Oleson J, Noble W, Coelho C, Ji H: Clinical trials for tinnitus: study populations, designs, measurement variables, and data analysis. Prog Brain Res 2007;166:499-509.
21.
Tyler RS, Parkinson AJ, Woodworth GG, Lowder MW, Gantz BJ: Performance over time of adult patients using the Ineraid or nucleus cochlear implant. J Acoust Soc Am 1997;102:508-522.
22.
Tyler RS, Rubinstein J, Pan T, Chang SA, Gogel SA, Gehringer A, Coelho C: Electrical stimulation of the cochlea to reduce tinnitus. Sem Hearing 2008;29:326-332.
23.
van Zon A, Peters JP, Stegeman I, Smit AL, Grolman W: Cochlear implantation for patients with single-sided deafness or asymmetrical hearing loss: a systematic review of the evidence. Otol Neurotol 2015;36:209-219.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.